FREE COMMUNICATIONS
FRIDAY, DECEMBER 10TH


FREE COMMUNICATIONS
16:30-17:30

  • ROOM C1
    Jury: Karin Andersson (Sweden) & Silvia Vannuccini (Italy) 

    – Association between endometriosis and preterm birth according to the disease phenotype: a multicenter prospective comparative study in France, Louis Marcellin (France)
    – The endometrial impact of the Selective Progesterone Receptor Modulator (SPRM), Ulipristal acetate (UPA) is reversible, Rohan Chodankar (United Kingdom)
    – Endometriosis is a possible risk factor for premature cardiovascular disease, Jessica Blom (Canada)
    – Identification of women with endometriosis: a simple questionnaire-based screening tool, Arnaud Fauconnier (France)
    – Effects of relugolix combination therapy on endometriosis-associated pain and analgesic use in SPIRIT studies: overall study and European populations, Christian Becker (United Kingdom)
    – Recovery of Bone Mineral Density (BMD) after long term treatment with linzagolix in women with endometriosis: results from a phase 2b dose-ranging trial, Jacques Donnez (Belgium)

  • ROOM C2
    Jury: Kirsten Hald (Norway) & Lalit Kumar Parameswaran Grace (Sweden)

    – Diet quality and perceived effects of dietary changes in Dutch endometriosis patients: an observational study, Iris Krabbenborg (Netherlands)
    – Relugolix combination therapy improves all dimensions of quality of life in women with endometriosis-associated pain: results from the SPIRIT program, Linda Giudice (USA)
    – The sonographic and symptomatic impact after combined oral contraceptive continuous regimens in endometriosis and adenomyosis patients, Pilar Carrillo Torres (Spain)
    – Uterine artery section during parametrectomy for deep infiltrating endometriosis and pregnancy outcome, Anna Katarzyna Stepniewska (Italy)
    – Abnormal iron metabolism promotes fibrosis by inducing ferroptosis in endometriosis, Jinwei Miao (China)
    – Peritoneal fluid leptin levels in endometriosis: a retrospective cohort study, Cloé Vaineau (Switzerland)

  • ROOM C4
    Jury: Oskari Heikinheimo (Finland) & Kiriaki Papaikonomou (Sweden)

    – Toward an improved assessment of quality of life in endometriosis: evaluation of the Spanish version of the Endometriosis Health Profile 30, González-Cantó Eva (Spain)
    – Understanding the impact of endometriosis and chronic pelvic pain on women’s lives through a qualitative study, Lauren MacArthur (Australia)
    – Analysis of mutations in deep infiltrative endometriosis and focal adenomyosis, Louis Marcellin (France)
    – Transvaginal ultrasound for the diagnosis of endometriosis in the uterosacral ligaments, torus uterinus and posterior vaginal fornix: a prospective study, Cristian De Guirior (Spain)
    – Increased overall morbidity in women with endometriosis: a population-based follow-up study until age 50, Henna Rossi (Finland)
    – The effect of vasopressin injection on ovarian reserve in patients who had cystectomy for ovarian endometrioma; a new insight, Saeed Alborzi (Iran)

  • ROOMS 25 & 26
    Jury: Johanna Andersson (Sweden)  & Margit Dueholm (Denmark)

    – Nomogram predicting complex ureteral procedure in pelvic DIE surgery, Lou Donval (France)
    – Cannabis use for endometriosis-associated pain: a cross-sectional Canadian survey study, Mahsa Gholiof (Canada)
    – Influence of endometrioma size on assisted reproductive technology outcomes, Yaniv Dahan (France)
    – LINC01133 inhibits invasion and promotes proliferation in an endometriosis epithelial cell line, Quanah Hudson (Austria)
    – Patient-derived organoids from endometriosis as powerful experimental models for the endometriotic-pelvic crosstalk mechanisms, Shen Licong (China)
    – Analysis of IVF/ICSI outcomes of endometriosis patients with repeated implantation failure: influence of GnRH-a on endometriosis, Yundong Mao (China)


VIDEOS SESSION
16:30-17:30

  • Rooms 35 & 36
    Jury: Caroline Salminen Frisendahl (Sweden) & Helena Kopp Kallner (Sweden)

    – International and multicenter prospective diagnostic accuracy of transvaginal ultrasound for endometriosis using the International Deep Endometriosis Analysis (IDEA) terminology: pilot study, Mathew Leonardi (Canada)
    – It’s in the bag! A review of laparoscopic specimen retrieval, Elizabeth Miazga (Canada)
    – Hysteroscopy for retained products of conception, Sony Singh (Canada)
    – Surgical management of interstitial ectopic pregnancy, Sony Singh (Canada)
    – Alternative therapies for endometriosis pain in Canadians: a cross-sectional survey study, Mahsa Gholiof (Canada)
    – The surgically diagnosed endometriosis in young women in Finland – a register-based cross-sectional cohort study, Elina Rasp (Finland)
    – Surgical management of abdominal wall endometriosis, Erica Pascoal (Canada)
    – Performing laparoscopic adenomyomectomy with four-petal method to treat women with severe adenomyosis, Kristyna Hlinecka (Czech Republic)
    – Accessory and cavitated uterine mass: diagnostic challenge and laparoscopic excision, Joana Xavie (Portugal)


FREE COMMUNICATIONS
17:30-18:30

  • Room C1
    Jury: Caroline Salminen Frisendahl (Sweden) & Helena Kopp Kallner (Sweden)

    – Collagen I triggers directional migration, invasion and matrix remodeling of stroma cells in a 3D spheroid model of endometriosis, Martin Götte (Germany)
    – Endometriosis associates with decreased health-related quality of life (HRQoL) at age 46 – A population-based cohort analysis, Saara Vuontisjärvi (Finland)
    – Endometriosis and immunomodulatory treatment: effect on gestation and placental development in mice, Ludivine Doridot (France)
    – Effect of genetic variants on gene expression of the endocannabinoid system in the endometrium among women with and without endometriosis, Keisuke Tanaka (Australia)
    – Pregnancy and delivery outcomes in women after Operation for deeply infiltrating endometriosis, Popov Aleksander (Russia)
    – Gene expression in the endocannabinoid system in the endometrium during the menstrual cycle and comparison between women with and without endometriosis, Akwasi Amoako (Australia)

  • Room C2
    Jury: Kirsten Hald (Norway) & Lalit Kumar Parameswaran Grace (Sweden)

    – Relugolix combination therapy in European women with symptomatic uterine fibroids in the LIBERTY long-term extension study, Felice Petraglia (Italy)
    – Analysis of ultrasound-guided puncture and ethanol sclerotherapy of ovarian endometriomas, Arias Gallego Paula (Spain)
    – The forgotten questions: prevalence of abuse in women with endometriosis and relationship to mental health, Alyssa Gaerke (Canada)
    – Long Term Efficacy of Linzagolix for Treatment of Heavy Menstrual Bleeding (HMB) due to Uterine Fibroids (UF): 52-week results from two placebo-controlled, randomized, phase 3 trials, Hugh S. Taylor (USA)
    – Long term safety and tolerability of linzagolix for treatment of Heavy Menstrual Bleeding (HMB) due to Uterine Fibroids (UF): 52-week results from two placebo-controlled, randomized, phase 3 trials, Jacques Donnez (Belgium)
    – Magnetic resonance imaging T2-weighted high-intensity adenomyosis spots and reduced live birth rates in ART cycles for endometriosis, Mathilde Bourdon (France)

  • Room 4
    Jury: Oskari Heikinheimo (Finland) & Kiriaki Papaikonomou (Sweden)

    – Examining the link between environmental toxin exposure and uterine leiomyoma: a systematic review, Jasmine Sodhi (Canada)
    – Efficacy and safety of vilaprisan in the treatment of heavy menstrual bleeding due to uterine fibroids: Data from the ASTEROID 3 phase 3 clinical study, Thomas Faustmann (Germany)
    – Investigation of the role of platelets in the etiopathogenesis of adenomyosis, Stefania Mosele (Belgium)
    – Identifying common pathogenic mechanisms in deep endometriotic nodules and uterine adenomyosis, Christina Anna Stratopoulou (Belgium)
    – Morcellation during total laparoscopic hysterectomies: implications of the use of a contained bag system, Catherine Bergeron (Canada)
    – “Gain Fading”, a new reliable 3D transvaginal ultrasonographic (TVUS) feature helps in diagnosing histological proven Adenomyosis using BCL6 biomarker in cases of reproductive failure, Hosam Zaki (Egypt)

  • Rooms 25 & 26
    Jury: Johanna Andersson (Sweden)  & Margit Dueholm (Denmark)

    – Safety and efficacy of Womed Leaf™, a novel barrier film to prevent intrauterine adhesion formation after hysteroscopic myomectomy: the PREG1 clinical trial, Huberlant Balas Stephanie (France)
    – ART outcomes in endometrioma patients undergoing sclerotherapy versus laparoscopic cystectomy; prospective cross sectional study, Saeed Alborzi (Iran)
    – How many embryo transfers are needed to achieve the first live birth in women with endometriosis depending on disease localization? Alexandra Kohl Schwartz (Switzerland)
    – MRI assessment of postoperative uterine isthmus thickness after resection of retro cervical space and utero-sacral ligament endometriosis, Charles-André Philip (France)
    – Laparoscopic treatment of bladder endometriosis using CO2 laser: safety, long-term efficacy and pregnancies in a series of 207 cases in a single referral center, Michelle Soares (Belgium)
    – Efficacy of virtual reality as a pain and anxiety distraction strategy on office hysteroscopy. Results of the first 52 patients, Marín Garrayo Sara (Spain)

  • Rooms 35 & 36
    Jury: Caroline Salminen Frisendahl (Sweden) & Helena Kopp Kallner (Sweden)

    – Individualized medicine using 3D printing technology in gynecology: a scoping review, Sony Singh (Canada)
    – The fragility of statistically significant results in gynecologic surgery: a systematic review, Erica Pascoal (Canada)
    – Perinatal outcomes of patients treated with hysteroscopy for Asherman´s syndrome, Zdenka Lisa (Czech Republic)
    – Adjuvant use of melatonin for pain management in dysmenorrhea – a double-blind, randomized, placebo-controlled trial, Lisa Söderman (Sweden)
    – A non-invasive algorithm based on pain and indirect ultrasonographic signs identifies patients with deep endometriosis at first consultancy, Eva González Cantó (Spain)
    – Myofascial pelvic pain and central sensitization related symptoms in deep endometriosis patients, Lara Quintas-Marques (Spain)